As of May 29
| +0.06 / +0.22%|
The 9 analysts offering 12-month price forecasts for Mindray Medical International Ltd have a median target of 29.00, with a high estimate of 35.00 and a low estimate of 20.00. The median estimate represents a +7.53% increase from the last price of 26.97.
The current consensus among 10 polled investment analysts is to Buy stock in Mindray Medical International Ltd. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.